- Report
- February 2021
- 360 Pages
United States
From €2331EUR$2,400USD£2,011GBP
The Intelence market is a subset of the Infectious Diseases Drugs market, focusing on drugs used to treat HIV/AIDS. Intelence drugs are antiretroviral medications that work by blocking the action of the HIV-1 enzyme, reverse transcriptase, which is responsible for the replication of the virus. These drugs are used to reduce the amount of virus in the body, allowing the immune system to fight the infection. Intelence drugs are typically used in combination with other antiretroviral medications to maximize their effectiveness.
Intelence drugs are used to treat HIV/AIDS in both adults and children, and are an important part of the global effort to combat the disease. They are also used to prevent HIV transmission from mother to child during pregnancy, labor, and delivery.
Some companies in the Intelence market include Gilead Sciences, Bristol-Myers Squibb, Merck, and Janssen Pharmaceuticals. Show Less Read more